2014 BDO Life Sciences RiskFactor Report

August 2014

Our second annual Life Sciences RiskFactor Report, which analyzes the 10-K filings of the 100 largest companies on the NASDAQ Biotechnology Index by revenue to identify the top 25 risks facing the industry, found that risks associated with supply chains, IP infringement and litigation are rising. With many life sciences companies relying on third-parties to bring their products to market, they face concerns related to product liability issues and insurance-related costs. In addition, more companies are focused on protecting their IP and adhering to the evolving regulatory landscape.